Role of axonal transport in neurodegenerative diseases

Annual Review of Neuroscience

Volumn 31, Issue , 2008, Pages 151-173

  De Vos, Kurt J ^a   Grierson, Andrew J ^b   Ackerley, Steven ^a   Miller, Christopher C J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Charcot Marie tooth disease; Huntington's disease; Motor neuron disease; Parkinson's disease

Indexed keywords

DYNACTIN; KINESIN; POLYGLUTAMINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXCITOTOXICITY; GENE DISRUPTION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; MICROTUBULE; MITOCHONDRION; MOLECULAR DYNAMICS; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; MUTANT; MYELINATION; NERVE FIBER TRANSPORT; NERVE FUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SOD1 GENE; SPINAL MUSCULAR ATROPHY;

ALZHEIMER DISEASE; ANIMALS; AXONAL TRANSPORT; AXONS; CENTRAL NERVOUS SYSTEM; CHARCOT-MARIE-TOOTH DISEASE; HUMANS; HUNTINGTON DISEASE; MOTOR NEURON DISEASE; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 48249102303     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.31.061307.090711     Document Type: Review

References (146)

1. Abou-Sleiman PM, Muqit MM, Wood NW. 2006. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7:207-19
2. Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, et al. 2004. p38a stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell Neurosci. 26:354-64
3. Ackerley S, Grierson AJ, Brownlees J, Thornhill P, Anderton BH, et al. 2000. Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 150:165-75
4. Ackerley S, James PA, Kalli A, French S, Davies KE, Talbot K. 2006. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum. Mol. Genet. 15:347-54
5. Ackerley S, Thornhill P, Grierson AJ, Brownlees J, Anderton BH, et al. 2003. Neurofilament heavy chain side-arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161:489-95
6. Ahmad FJ, He Y, Myers KA, Hasaka TP, Francis F, et al. 2006. Effects of dynactin disruption and dynein depletion on axonal microtubules. Traffic 7:524-37
7. Amarilio R, Ramachandran S, Sabanay H, Lev S. 2005. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280:5934-44
8. Araki Y, Kawano T, Taru H, Saito Y, Wada S, et al. 2007. The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J. 26:1475-86
9. Baas PW, Karabay A, Qiang L. 2005. Microtubules cut and run. Trends Cell Biol. 15:518-24
10. Ballatore C, Lee VM, Trojanowski JQ. 2007. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8:663-72
11. Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. 2007. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J. Neurosci. 27:422-30
12. Beaulieu JM, Nguyen MD, Julien JP. 1999. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147:531-44
13. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, et al. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103:16021-26
14. Boillee S, Vande Velde C, Cleveland DW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59
15. Bommel H, Xie G, Rossoll W, Wiese S, Jablonka S, et al. 2002. Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell Biol. 159:563-69
16. Bowman AB, Kamal A, Ritchings BW, Philp AV, McGrail M, et al. 2000. Kinesin-dependent axonal transport is mediated by the Sunday driver (SYD) protein. Cell 103:583-94
17. Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, et al. 2002. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 11:2837-44
18. Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, et al. 2000. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J. Cell Sci. 113:401-7
19. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, et al. 1997. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-38
20. Chang DT, Rintoul GL, Pandipati S, Reynolds IJ. 2006. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol. Dis. 22:388-400
21. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. 2003. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160:189-200
22. Coleman M. 2005. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6:889-98
23. Collard J-F, Cote F, Julien J-P. 1995. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375:61-64
24. Cote F, Collard J-F, Julien J-P. 1993. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73:35-46
25. Couillard-Després S, Zhu QZ, Wong PC, Price DL, Cleveland DW, Julien JP. 1998. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95:9626-30
26. Deinhardt K, Salinas S, Verastegui C, Watson R, Worth D, et al. 2006. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52:293-305
27. Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, et al. 2006. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc. Natl. Acad. Sci. USA 103:9595-600
28. De Vos K, Severin F, Van Herreweghe F, Vancompernolle K, Goossens V, et al. 2000. Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J. Cell Biol. 149:1207-14
29. De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, et al. 2007. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16:2720-28
30. de Waegh S, Brady ST. 1990. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the Trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci. 10:1855-65
31. de Waegh SM, Lee VM-Y, Brady ST. 1992. Local modulation of neurofilament phosphorylation, axonal caliber and slow axonal transport by myelinating Schwann cells. Cell 68:451-63
32. Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, et al. 2007. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci. 27:3571-83
33. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, et al. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166:121-31
34. Glued subunit of dynactin. Hum. Mol. Genet. 6:2205-12
35. Evans K, Keller C, Pavur K, Glasgow K, Conn B, Lauring B. 2006. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc. Natl. Acad. Sci. USA 103:10666-71
36. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, et al. 2004. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36:602-6
37. Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, et al. 2004. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113:231-42
38. Fink JK. 2006. Hereditary spastic paraplegia. Curr. Neurol. Neurosci. Rep. 6:65-76
39. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, et al. 2002. alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4:160-64
40. Garcia ML, Lobsiger CS, Shah SB, Deerinck TJ, Crum J, et al. 2003. NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163:1011-20
41. Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, et al. 2004. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127-38
42. Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, et al. 2006. Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 7:873-88
43. Guidato S, Tsai L-H, Woodgett J, Miller CCJ. 1996. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem.. 66:1698-706
44. Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, et al. 2003. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25-40
45. Hadano S, Benn SC, Kakuta S, Otomo A, Sudo K, et al. 2005. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet. 15:233-50
46. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, et al. 2003. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300:808-12
47. Hardy J. 2006. A hundred years of Alzheimer's disease research. Neuron 52:3-13
48. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. 2006. Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60:389-98
49. Hirokawa N, Takemura R. 2005. Molecular motors and mechanisms of directional transport in neurons. Nat. Rev. Neurosci. 6:201-14
50. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T. 2003. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci. 23:8967-77
51. Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, et al. 2004. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet. 36:597-601
52. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, et al. 1999. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24:751-62
53. Jacquier A, Buhler E, Schafer MK, Bohl D, Blanchard S, et al. 2006. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann. Neurol. 60:105-17
54. Jung C, Lee S, Ortiz D, Zhu Q, Julien JP, Shea TB. 2005. The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Brain Res. Mol. Brain Res. 141:151-55
55. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LB. 2001. Kinesin-mediated axonal transport of a membrane compartment containing B-secretase and presenilin-1 requires APP. Nature 414:643-48
56. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, et al. 1997. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol. Chem. 272:18518-21
57. Kiebler MA, Bassell GJ. 2006. Neuronal RNA granules: movers and makers. Neuron 51:685-90
58. Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, et al. 2005. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169:561-67
59. Konecna A, Frischknecht R, Kinter J, Ludwig A, Steuble M, et al. 2006. Calsyntenin-1 docks vesicular cargo to kinesin-1. Mol. Biol. Cell 17:3651-63
60. Kriz J, Nguyen M, Julien J. 2002. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 10:268-78
61. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, et al. 2002. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715-27
62. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, et al. 2005. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci. 25:2386-95
63. Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, et al. 2007. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin L. J. Neurosci. 27:7011-20
64. Lee MK, Marszalek JR, Cleveland DW. 1994. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13:975-88
65. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-64
66. Lee WC, Yoshihara M, Littleton JT. 2004. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. USA 101:3224-29
67. Glued perturbs dynactin function and induces protein aggregation. J. Cell Biol. 172:733-45
68. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, et al. 2001. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. USA 98:12742-47
69. Lobsiger CS, Garcia ML, Ward CM, Cleveland DW. 2005. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. Proc. Natl. Acad. Sci. USA 102:10351-56
70. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, et al. 1994. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1077-86
71. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. 2006. Mitochondria are a direct site of Abeta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15:1437-49
72. Martin N, Jaubert J, Gounon P, Salido E, Haase G, et al. 2002. A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32:443-47
73. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, et al. 2002. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol. Chem. 277:29626-33
74. McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, et al. 2003. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. 54:748-59
75. McGuire JR, Rong J, Li SH, Li XJ. 2005. Interaction of huntingtin-associated protein-1 with kinesin light chain: implications in intracellular traffickingin neurons. J. Biol. Chem. 281:3552-59
76. Millecamps S, Robertson J, Lariviere R, Mallet J, Julien JP. 2006. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J. Neurochem. 98:926-38
77. Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. 2006. The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci. 29:280-85
78. Miller KE, Sheetz MP. 2004. Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 117:2791-804
79. Monani UR. 2005. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuronspecific disease. Neuron. 48:885-96
80. Morfini G, Pigino G, Opalach K, Serulle Y, Moreira JE, et al. 2007. l-methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc. Natl. Acad. Sci. USA 104:2442-47
81. Morfini G, Pigino G, Szebenyi G, You Y, Pollema S, Brady ST. 2006. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9:907-16
82. Munch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, et al. 2005. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58:777-80
83. Muresan Z, Muresan V. 2005. Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J. Cell Biol. 171:615-25
84. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-13
85. Nguyen MD, D'Aigle T, Gowing G, Julien JP, Rivest S. 2004. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24:1340-49
86. Nguyen MD, Lariviere RC, Julien JP. 2001. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-47
87. Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, et al. 2003. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 12:1671-87
88. Pasinelli P, Brown RH. 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7:710-23
89. Patrick G, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-22
90. Pennetta G, Hiesinger P, Fabian-Fine R, Meinertzhagen I, Bellen H. 2002. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35:291-306
91. Perez-Olle R, Lopez-Toledano MA, Goryunov D, Cabrera-Poch N, Stefanis L, et al. 2005. Mutations in the neurofilament light gene linked to Charcot-Marie-Toodi disease cause defects in transport. J. Neurochem. 93:861-74
92. Pfister KK, Shah PR, Hummerich H, Russ A, Cotton J, et al. 2006. Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet. 2:e1
93. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. 2003. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23:4499-508
94. Puis I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, et al. 2003. Mutant dynactin in motor neuron disease. Nat. Genet. 33:455-56
95. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, et al. 2002. Motoneuron death triggered by a specific pathway downstream of Fas: potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-83
96. Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, et al. 2005. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37:771-76
97. Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, et al. 2006. Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol. 16:2166-72
98. Reid E. 2003. Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J. Med. Genet. 40:81-86
99. Reid E, Connell J, Edwards TL, Duley S, Brown SE, Sanderson CM. 2005. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum. Mol. Genet. 14:19-38
100. Roll-Mecak A, Vale RD. 2005. The Drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules. Curr. Biol. 15:650-55
101. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, et al. 2003. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163:801-12
102. Roy S, Coffee P, Smith G, Liem RKH, Brady ST, Black MM. 2000. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 20:6849-61
103. Rui Y, Tiwari P, Xie Z, Zheng JQ. 2006. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J. Neurosci. 26:10480-87
104. Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, et al. 2004. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J. Cell Sci. 117:1017-24
105. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, et al. 2006. Increased APP expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:29-42
106. Salinas S, Carazo-Salas RE, Proukakis C, Cooper JM, Weston AE, et al. 2005. Human spastin has multiple microtubule-related functions. J. Neurochem. 95:1411-20
107. Sanchez I, Hassinger L, Sihag RK, Cleveland DW, Mohan P, Nixon RA. 2000. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation. J. Cell Biol. 151:1013-24
108. Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, et al. 2006. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum. Mol. Genet. 15:307-18
109. Sasaki S, Iwata M. 2007. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 66:10-16
110. Schwarzschild MA, Cole RL, Hyman SE. 1997. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J. Neurosci. 17:3455-66
111. Seitz A, Kojima H, Oiwa K, Mandelkow EM, Song YH, Mandelkow E. 2002. Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J. 21:4896-905
112. Setou M, Nakagawa T, Seog D-H, Hirokawa N. 2000. Kinesin superfamiy motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288:1796-802
113. Shea TB, Yabe JT, Ortiz D, Pimenta A, Loomis P, et al. 2004. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J. Cell Sci. 117:933-41
114. Skehel PA, Fabian-Fine R, Kandel ER. 2000. Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. USA 97:1101-6
115. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388:839-40
116. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow E-M. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156:1051-63
117. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, et al. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-88
118. Sun D, Leung CL, Liem RKH. 1996. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk-5 and p35. J. Biol. Chem. 271:14245-51
119. Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, et al. 2003. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41-52
120. Tarrade A, Fassier C, Courageot S, Charvin D, Vitte J, et al. 2006. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum. Mol. Genet. 15:3544-58
121. Tofaris GK, Spillantini MG. 2007. Physiological and pathological properties of alpha-synuclein. Cell Mol. Life Sci. 64:2194-201
122. Topp JD, Gray NW, Gerard RD, Horazdovsky BF. 2004. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J. Biol. Chem. 279:24612-23
123. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, et al. 2003. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell Neurosci. 23:180-92
124. Trotti D, Rolfs A, Danbolt NC, Brown RHJ, Hediger MA. 1999. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2:427-33
125. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, et al. 2004. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell Biol. 24:8195-209
126. Tudor EL, Perkinton MS, Schmidt A, Ackerley S, Brownlees J, et al. 2005. ALS2/ALSIN regulates RAC-PAK signalling and neurite outgrowth. J. Biol. Chem.. 280:34735-40
127. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. 2006. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9:108-18
128. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W. 2002. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport 13:1067-70
129. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. 2006. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762:1068-82
130. Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, et al. 2001. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell Biol. 152:959-70
131. Wagner OT, Ascano J, Tokito M, Leterrier JF, Janmey PA, Holzbaur EL. 2004. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 15:5092-100
132. Wagner U, Utton M, Gallo J-M, Miller CCJ. 1996. Cellular phosphorylation of tau by GSK-3beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109:1537-43
133. Wallace DC. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39:359-407
134. Wang L, Brown A. 2002. Rapid movement of microtubules in axons. Curr. Biol. 12:1496-501
135. Wang L, Ho C-L, Sun D, Liem RKH, Brown A. 2000. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2:137-41
136. Wang X, Shaw WR, Tsang HT, Reid E, O'Kane CJ. 2007. Drosophila spichthyin inhihits BMP signaling and regulates synaptic growth and axonal microtubules. Nat. Neurosci. 10:177-85
137. Williamson TL, Bruijn LI, Zhu QZ, Anderson KL, Anderson SD, et al. 1998. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused hy a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 95:9631-36
138. Williamson TL, Cleveland DW. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:50-56
139. Wilquet V, De Strooper B. 2004. Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 14:582-88
140. Xiao S, McLean J, Robertson J. 2006. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762:1001-12
141. Xu Z, Cork LC, Griffin JW, Cleveland DW. 1993. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73:23-33
142. Yuan A, Rao MV, Kumar A, Julien JP, Nixon RA. 2003. Neurofilament transport in vivo minimally requires hetero-oligomer formation. J. Neurosci. 23:9452-58
143. Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, et al. 2004. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24:4657-67
144. Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. 1997. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol. 139:1307-15
145. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, et al. 2001. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587-97
146. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78